revenue growth
20–25 pct
FY 2027
management framework
OpenFilings analyst
Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.
Wait for plant commissioning, order visibility, and reconciliation of conflicting guidance.
Latest call · 2026-05-16Hold: the new plant could materially accelerate growth, but the investment case is not yet clean.
Commercial production is now targeted for end-June/early July after environmental-clearance delays; management cited INR250–300 crore of FY27 revenue from the plant and 20%–25% FY27 company growth, but analysts exposed unresolved inconsistencies between these figures and the much higher INR600–700 crore/INR900–1,000 crore longer-term claims. Cost inflation, weak domestic brand traction, and execution risk argue for waiting for commissioning and early utilization data.
Plant commissioning by end-June or early July is the key near-term catalyst after repeated delays caused by environmental clearance.
Initial utilization and order conversion will test the FY27 new-plant revenue expectation; management indicated 30%–40% utilization from Q2 FY27 and 80%+ within two years.
Phenol, crude-linked commodities, freight, and currency movements could pressure margins despite 3%–5% price increases and existing raw-material inventory.
Domestic brand visibility is expected to improve over the next 2–3 quarters, but management provided no quantified sales or EBITDA targets for the domestic business.
The Manak Tabra plant has INR334 crore of capex invested and could roughly double existing capacity, with management claiming 80% utilization potential and limited incremental fixed costs.
Aica’s technology and planned HPL products could improve the product mix, but the technology rollout and commercial contribution remain unquantified.
The business remains heavily export-led at approximately 75% of FY26 revenue, leaving it exposed to tariffs, geopolitical disruption, and competition with European suppliers.
The competitive moat remains unproven in domestic markets: analysts noted that Stylam is recognized by channel partners but not strongly preferred as a brand.
Management gave materially inconsistent plant revenue numbers: INR250–300 crore for FY27, INR300–400 crore over the next three quarters, INR600–700 crore the following year, and INR900–1,000 crore at peak, without reconciling the underlying capacity or timing math.
The plant has already shifted from an earlier November target to March and then June/July; further commissioning or ramp-up slippage remains a material risk.
Management could not quantify the raw-material cost increase versus price increases or provide a downside EBITDA scenario if elevated oil and freight costs persist.
Aica’s transaction and remaining legalities were still pending, while the promoter group stated it must tender the remaining 40% stake under the agreement; the future ownership and governance implications are not fully clear.
Aica-related incremental business is only potential: management said Aica Global was not currently purchasing from India and that discussions would occur after the deal is completed.
revenue growth
20–25 pct
FY 2027
management framework
ebitda
22 pct
FY 2028
management framework
OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.